Cargando…

Cross-sectional and longitudinal measures of chitinase proteins in amyotrophic lateral sclerosis and expression of CHI3L1 in activated astrocytes

OBJECTIVE: Amyotrophic lateral sclerosis (ALS) is a complex disease with numerous pathological mechanisms resulting in a heterogeneous patient population. Using biomarkers for particular disease mechanisms may enrich a homogeneous subset of patients. In this study, we quantified chitotriosidase (Chi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vu, Lucas, An, Jiyan, Kovalik, Tina, Gendron, Tania, Petrucelli, Leonard, Bowser, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Neuro-Inflammation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147184/ https://www.ncbi.nlm.nih.gov/pubmed/31937582 http://dx.doi.org/10.1136/jnnp-2019-321916

Ejemplares similares

Association of obesity with disease outcome in multiple sclerosis
por: Lutfullin, Isabel, et al.
Publicado: (2023)

Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders
por: Lu, Angelo, et al.
Publicado: (2022)

Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis
por: Leppert, David, et al.
Publicado: (2023)

Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study
por: Gallo, Valentina, et al.
Publicado: (2016)

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
por: Ramanathan, Sudarshini, et al.
Publicado: (2018)

Correlation between leukocyte phenotypes and prognosis of amyotrophic lateral sclerosis
por: Cui, Can, et al.
Publicado: (2022)

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
por: Stellmann, Jan-Patrick, et al.
Publicado: (2017)

Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis
por: Costa, Júlia, et al.
Publicado: (2021)

Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens
por: Hacohen, Yael, et al.
Publicado: (2013)

Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre
por: Paterson, Ross W, et al.
Publicado: (2013)

Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
por: Mathey, Emily K, et al.
Publicado: (2015)

Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease
por: Rossi, Meghan, et al.
Publicado: (2015)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
por: Waters, Patrick, et al.
Publicado: (2016)

Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias
por: King, Eleanor, et al.
Publicado: (2018)

Autologous haematopoietic stem cell transplantation for neurological diseases
por: Burman, Joachim, et al.
Publicado: (2018)

LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes
por: Binks, Sophie N M, et al.
Publicado: (2018)

CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications
por: Kaneko, Kimihiko, et al.
Publicado: (2018)

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
por: Lang, Bethan, et al.
Publicado: (2017)

Peripheral immunophenotype in dementia with Lewy bodies and Alzheimer’s disease: an observational clinical study
por: Amin, Jay, et al.
Publicado: (2020)

Neuroinflammation predicts disease progression in progressive supranuclear palsy
por: Malpetti, Maura, et al.
Publicado: (2021)

Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies
por: McGinty, Ronan N, et al.
Publicado: (2021)

LGI1 antibody encephalitis: acute treatment comparisons and outcome
por: Rodriguez, Andrew, et al.
Publicado: (2022)

Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management
por: Abboud, Hesham, et al.
Publicado: (2021)

Clinical spectrum of high-titre GAD65 antibodies
por: Budhram, Adrian, et al.
Publicado: (2021)

Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management
por: Abboud, Hesham, et al.
Publicado: (2021)

TNF-α inhibitors used as steroid-sparing maintenance monotherapy in parenchymal CNS sarcoidosis
por: Hilezian, Frédéric, et al.
Publicado: (2021)

In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer’s disease
por: Low, Audrey, et al.
Publicado: (2021)

Neuromyelitis optica spectrum disorder: pregnancy-related attack and predictive risk factors
por: Wang, Liang, et al.
Publicado: (2021)

Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders
por: Oertel, Frederike Cosima, et al.
Publicado: (2023)

The Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis: Signals From the CNS and Beyond
por: Gaur, Nayana, et al.
Publicado: (2020)

CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2020)

ARHGEF28 p.Lys280Metfs40Ter in an amyotrophic lateral sclerosis family with a C9orf72 expansion
por: Farhan, Sali M.K., et al.
Publicado: (2017)

The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients
por: Collins, Mahlon, et al.
Publicado: (2012)

Longitudinal biomarkers in amyotrophic lateral sclerosis
por: Huang, Fen, et al.
Publicado: (2020)

Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis
por: Bakkar, Nadine, et al.
Publicado: (2017)

Myofiber Type Shift in Extraocular Muscles in Amyotrophic Lateral Sclerosis
por: Behzadi, Arvin, et al.
Publicado: (2023)

Monocyte-Derived Macrophages Contribute to Chitinase Dysregulation in Amyotrophic Lateral Sclerosis: A Pilot Study
por: Gaur, Nayana, et al.
Publicado: (2021)

Clinical evaluation of automated quantitative MRI reports for assessment of hippocampal sclerosis
por: Goodkin, Olivia, et al.
Publicado: (2020)

Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imaging
por: Xiao, Hua-Feng, et al.
Publicado: (2015)

Dysregulation of Astrocytic HMGB1 Signaling in Amyotrophic Lateral Sclerosis
por: Brambilla, Liliana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sddh7l5pi8mj9shbhm07via2dr